The healthcare landscape for blood sugar is changing, and transdermal GLP-1 delivery systems represent a promising development. Unlike injections, this technique offers a less invasive way to deliver GLP-1 drugs. These transdermal systems steadily release the drug through the surface offering a even amount of the active agent, which can optimize… Read More